Nashville's Sarah Cannon Research Institute (SCRI) has announced that it has finalized an agreement with Yale Cancer Center and the Smilow Cancer Hospital at Yale-New Haven to "advance cancer research."

As part of the collaboration, SCRI physician scientists will partner with physician scientists from Yale Cancer Center to discuss strategic scientific priorities and develop clinical research protocols.

Other components of the partnership include the opening of a clinical trial management office on the Yale Cancer Center campus in New Haven, CT and for Smilow Cancer Hospital to develop a network of community-based sites that will participate in the program. SCRI’s role in the management of the clinical trials office will be to provide assistance in opening research studies at Yale and within their community network, as well as to augment clinical trial availability and participation of patients in Yale’s service area.